Atlas Trials

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

Clinical trial NCT00824421 · COMPLETED

Trial details

NCT number
NCT00824421
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1
Start date
2009-02-01
Primary completion
2011-10-01
Enrollment
195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.